blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2981552

EP2981552 - BISPECIFIC ANTIBODIES SPECIFIC FOR FAP AND DR5, ANTIBODIES SPECIFIC FOR DR5 AND METHODS OF USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.12.2019
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  11.01.2019
FormerGrant of patent is intended
Status updated on  04.01.2019
FormerExamination is in progress
Status updated on  17.12.2018
FormerGrant of patent is intended
Status updated on  27.08.2018
FormerExamination is in progress
Status updated on  10.03.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Roche Glycart AG
Wagistrasse 18
8952 Schlieren / CH
[2016/06]
Inventor(s)01 / BRUENKER, Peter
Burgwiesenstrasse 3c
CH-8335 Hittnau / CH
02 / DAOUTI, Sherif
63 Minnisink Road
Totowa, New Jersey 07512 / US
03 / FENG, Ningping
6 Bayview Court South
Richmond Hill, Ontario L4E 3E6 / CA
04 / FERRARA KOLLER, Claudia
Haenibueel 13
CH-6300 Zug / CH
05 / GEORGES, Guy
Am Berggraben 11
82392 Habach / DE
06 / GRAU-RICHARDS, Sandra
Breitestrasse 16
CH-8903 Birmensdorf ZH / CH
07 / HOSSE, Ralf
Schmiedstrasse 8
CH-6330 Cham / CH
08 / KLEIN, Christian
Chruezacherweg 41
CH-8906 Bonstetten / CH
09 / KOENIG, Maximiliane
Richard-Strauss-Strasse 5
82049 Pullach / DE
10 / MOELLEKEN, Joerg
Ossietzystrasse 2
80686 Muenchen / DE
11 / MOESSNER, Ekkehard
Felsenburgweg 5
CH-8280 Kreuzlingen / CH
12 / NIU, Huifeng
2050 Wood Road
Scotch Plains, New Jersey 07076 / US
13 / PACKMAN, Kathryn E.
65 Andrew Street
Newton, Massachusetts 02461 / US
14 / RUNZA, Valeria
Bichler Strasse 3a
82377 Penzberg / DE
15 / SEEBER, Stefan
Mitterweg 2
82404 Sindelsdorf / DE
16 / UMANA, Pablo
Felsenrainstrasse 28
CH-8832 Wollerau / CH
17 / WALDHAUER, Inja
Schlierenstrasse 39
CH-8902 Urdorf / CH
18 / WANG, Huisheng
292 Savoy Avenue
Edison, New Jersey 08820 / US
19 / WEISER, Barbara
Koenigbergstrasse 51
82404 Sindelsdorf / DE
 [2016/06]
Representative(s)Townsend, Carolin
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2016/06]
Application number, filing date14714275.601.04.2014
[2016/06]
WO2014EP56511
Priority number, dateUS201361808128P03.04.2013         Original published format: US 201361808128 P
[2016/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014161845
Date:09.10.2014
Language:EN
[2014/41]
Type: A1 Application with search report 
No.:EP2981552
Date:10.02.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.2014 takes the place of the publication of the European patent application.
[2016/06]
Type: B1 Patent specification 
No.:EP2981552
Date:13.02.2019
Language:EN
[2019/07]
Search report(s)International search report - published on:EP09.10.2014
ClassificationIPC:C07K16/28, C07K16/40, C07K16/30, C07K16/46, A61K39/395, A61P35/00
[2016/06]
CPC:
C07K16/40 (EP,US); C07K16/2875 (KR,US); C07K16/2878 (EP,KR,US);
A61K39/39533 (KR); A61K39/39558 (US); A61P35/00 (EP);
A61P35/02 (EP); A61P43/00 (EP); C07K16/30 (EP,KR,US);
A61K2039/505 (EP,US); C07K2317/21 (EP,US); C07K2317/24 (EP,US);
C07K2317/31 (EP,KR,US); C07K2317/33 (EP,US); C07K2317/35 (EP,KR,US);
C07K2317/52 (EP,US); C07K2317/55 (EP,KR,US); C07K2317/565 (KR);
C07K2317/62 (KR); C07K2317/624 (EP,US); C07K2317/64 (EP,US);
C07K2317/66 (EP,US); C07K2317/73 (EP,KR,US); C07K2317/75 (EP,KR,US);
C07K2317/92 (EP,US); C07K2317/94 (EP,US); C07K2319/00 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/06]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:BISPEZIFISCHE ANTIKÖRPER SPEZIFISCH FÜR FAP UND DR5, SPEZIFISCHE ANTIKÖRPER FÜR DR5 UND VERFAHREN ZUR VERWENDUNG[2016/06]
English:BISPECIFIC ANTIBODIES SPECIFIC FOR FAP AND DR5, ANTIBODIES SPECIFIC FOR DR5 AND METHODS OF USE[2016/06]
French:ANTICORPS BISPÉCIFIQUES DIRIGÉS CONTRE FAP ET DR5, ANTICORPS SPÉCIFIQUES DIRIGÉS CONTRE DR5 ET LEURS PROCÉDÉS D'UTILISATION[2016/06]
Entry into regional phase03.11.2015National basic fee paid 
03.11.2015Designation fee(s) paid 
03.11.2015Examination fee paid 
Examination procedure03.11.2015Examination requested  [2016/06]
26.04.2016Amendment by applicant (claims and/or description)
14.03.2017Despatch of a communication from the examining division (Time limit: M06)
30.08.2017Reply to a communication from the examining division
09.01.2018Despatch of a communication from the examining division (Time limit: M04)
05.04.2018Reply to a communication from the examining division
28.08.2018Communication of intention to grant the patent
17.12.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
17.12.2018Fee for grant paid
17.12.2018Fee for publishing/printing paid
17.12.2018Receipt of the translation of the claim(s)
Opposition(s)14.11.2019No opposition filed within time limit [2020/04]
Fees paidRenewal fee
30.03.2016Renewal fee patent year 03
10.04.2017Renewal fee patent year 04
09.04.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.04.2014
AL13.02.2019
CY13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
MC13.02.2019
MK13.02.2019
MT13.02.2019
RS13.02.2019
SI13.02.2019
SK13.02.2019
SM13.02.2019
IE01.04.2019
LU01.04.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
[2022/31]
Former [2021/34]HU01.04.2014
AL13.02.2019
CY13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
MC13.02.2019
MT13.02.2019
RS13.02.2019
SI13.02.2019
SK13.02.2019
SM13.02.2019
IE01.04.2019
LU01.04.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2021/33]HU01.04.2014
AL13.02.2019
CY13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
MC13.02.2019
RS13.02.2019
SI13.02.2019
SK13.02.2019
SM13.02.2019
IE01.04.2019
LU01.04.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2021/26]AL13.02.2019
CY13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
MC13.02.2019
RS13.02.2019
SI13.02.2019
SK13.02.2019
SM13.02.2019
IE01.04.2019
LU01.04.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2020/21]AL13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
MC13.02.2019
RS13.02.2019
SI13.02.2019
SK13.02.2019
SM13.02.2019
IE01.04.2019
LU01.04.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2020/13]AL13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
MC13.02.2019
RS13.02.2019
SI13.02.2019
SK13.02.2019
SM13.02.2019
LU01.04.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2020/04]AL13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
MC13.02.2019
RS13.02.2019
SK13.02.2019
SM13.02.2019
LU01.04.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2020/02]AL13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
MC13.02.2019
RS13.02.2019
SK13.02.2019
SM13.02.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2019/51]AL13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
RS13.02.2019
SK13.02.2019
SM13.02.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2019/49]AL13.02.2019
CZ13.02.2019
DK13.02.2019
EE13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
RS13.02.2019
SK13.02.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2019/48]DK13.02.2019
FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
RS13.02.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2019/39]FI13.02.2019
HR13.02.2019
LT13.02.2019
LV13.02.2019
RS13.02.2019
BG13.05.2019
NO13.05.2019
IS13.06.2019
PT13.06.2019
Former [2019/38]FI13.02.2019
LT13.02.2019
BG13.05.2019
NO13.05.2019
PT13.06.2019
Former [2019/33]FI13.02.2019
LT13.02.2019
NO13.05.2019
PT13.06.2019
Cited inInternational search[IDAY]US2007031414  (ADAMS CAMELLIA W [US]);
 [IDAY]WO2011039126  (ROCHE GLYCART AG [CH], et al);
 [XDAY]WO2012020006  (ROCHE GLYCART AG [CH], et al)
by applicantUS4186567
 US4676980
 WO9305804
 US5202238
 US5204244
 WO9308829
 US5500362
 US5565332
 WO9730087
 US5731168
 US5821337
 WO9858964
 WO9922764
 US5959177
 US5969108
 US6040498
 WO0061739
 US6171586
 WO0129246
 US6267958
 WO0231140
 US6417429
 US6420548
 US2002164328
 WO03011878
 US2003115614
 US6602684
 US2003157108
 WO03085119
 WO03084570
 WO03085107
 US2004093621
 US6737056
 US2004110704
 US2004110282
 US2004109865
 US2004132140
 WO2004056312
 US2004132066
 WO2004065540
 WO2005035586
 WO2005035778
 US2005123546
 WO2005053742
 WO2005100402
 US2005260186
 US6982321
 US2006025576
 WO2006029879
 WO2006044908
 US2006104968
 US7087409
 WO2006083971
 US7125978
 US2007031414
 US7332581
 US2008069820
 EP1922337
 WO2008077546
 US7521541
 US7527791
 WO2009080252
 WO2009080253
 WO2009080251
 WO2009080254
 WO2009089004
 US7695936
 WO2010136172
 WO2010145792
 WO2011039126
 WO2011098520
 WO2012020006
 WO2013026831
 WO2012EP55393
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.